ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Hepatitis C"

  • 2022 American Transplant Congress

    Ultra-Short Duration Prophylaxis for Hepatitis C Donor Positive to Recipient Negative Simultaneous Kidney/Pancreas Transplants

    G. Gupta, I. Yakubu, A. Khan, R. Sterling

    Virginia Commonwealth University, Richmond, VA

    *Purpose: Recent trials have successfully utilized a strategy of hepatitis C virus (HCV) D+ [Donor nucleic acid test (NAT) positive]/R- (Recipient NAT negative) kidney and/or…
  • 2022 American Transplant Congress

    Use of Kidneys from Hepatitis C Nat Positive Donors for Uninfected Recipients: Early Results from a Rural Appalachian Kidney Transplant Program

    B. Gillis1, F. Afridi1, R. Lopez1, V. Chaudhary1, D. Kannabhiran1, C. Fagella1, R. Zomak1, K. Meyer1, M. Thornberg1, L. Biondi2

    1Department of Surgery, West Virginia University, Morgantown, WV, 2Department of Surgery, West Virginia University, Morgantown, WV, WV

    *Purpose: Increasing mismatch between kidneys available for transplant and the number of patients on the transplant wait list has led to research into novel sources…
  • 2022 American Transplant Congress

    Is Donor Hepatitis C Virus Infection Status Associated with Early Post-Kidney Transplant Failure in the Era of Direct-Acting Antiviral Medications?

    S. Sutcliffe1, S. Chang1, D. Stewart2, M. Ji3, K. Lentine4, G. Gupta5, T. Alhamad6

    1Washington University School of Medicine, Saint Louis, MO, 2United Network for Organ Sharing, Richmond, VA, 3Washington University in St. Louis School of Medicine, Saint Louis, MO, 4Saint Louis University School of Medicine, Saint Louis, MO, 5Virginia Commonwealth University School of Medicine, Richmond, VA, 6Washington University School of Medicine at St. Louis, Saint Louis, MO

    *Purpose: To determine the influence of donor hepatitis C virus (HCV) infection status on early kidney transplant (KT) failure in HCV negative recipients in the…
  • 2022 American Transplant Congress

    Outcomes in Hepatitis C (HCV) Viremic Grafts to HCV Negative Recipients in Heart Transplantation: A Multicenter Study of Differing Treatment Strategies

    K. Ryland1, B. Aqel2, D. Steidley2, P. Patel1, S. Pungpapong3

    1Mayo Clinic, Jacksonville, FL, 2Mayo Clinic, Phoenix, AZ, 3Mayo Clinic College of Medicine, Jacksonville, FL

    *Purpose: Using HCV viremic grafts for heart transplantation (HT) improves donor supply and shortens wait times. However, treatment strategies are variable post-transplant. This study aims…
  • 2022 American Transplant Congress

    Is Stigma of Hepatitis C with KDPI Still Justified?

    F. Siddiqui, P. N. Chotai, A. Logan, A. Schenk, K. Washburn, A. Limkemann

    Comprehensive Transplant Center, The Ohio State University Wexner Medical Center, Columbus, OH

    *Purpose: Kidney donor profile index (KDPI) is composed of 10 variables that are used to estimate the quality of a kidney. Hepatitis C virus (HCV)…
  • 2022 American Transplant Congress

    Patient and Graft Survival for Simultaneous Kidney and Liver Transplant Recipients from Hepatitis C Viremic Donors: A Unos Database Analysis

    Z. Haddadin, A. Parsikia, H. Kaul, N. Chandolias, R. Zaki, K. Khanmoradi

    General Surgery, Einstein Medical Center-Philadelphia, Philadelphia, PA

    *Purpose: We aimed to compare recipient and graft survival for simultaneous kidney and liver transplant (SLK) recipients from hepatitis C virus (HCV) nucleic acid test…
  • 2022 American Transplant Congress

    BK Polyomavirus and Cytomegalovirus Infections in Kidney Transplantation from Hepatitis C Positive Donors to Uninfected Recipients

    I. Yakubu, V. Amrutiya, I. Moinuddin, M. Levy, G. Gupta, A. Azhar

    Virginia Commonwealth University, Richmond, VA

    *Purpose: Transplantation of hepatitis C viremic (HCV) donor kidneys into uninfected recipients (D+/R-) is becoming more common in the United States. However, the long-term risks…
  • 2022 American Transplant Congress

    Current State of Use of Hepatitis C Viremic Donor Organs in Negative Recipients in the United States: A National Survey

    K. Ryland1, K. Hattori2, J. Steinbrink3, N. Theodoropoulos4, M. Ison5

    1Mayo Clinic, Jacksonville, FL, 2Duke university hospital, Durham, NC, 3Duke University, Durham, NC, 4University of Massachusetts Medical School, Worcester, MA, 5Northwestern University Comprehensive Transplant Center, Chicago, IL

    *Purpose: Since the advent of direct-acting antiviral (DAA) therapy, use of hepatitis C (HCV) viremic donor organs in HCV negative recipients has become more common.…
  • 2022 American Transplant Congress

    Eliminating Hepatitis C Positive Status from Kidney Donor Profile Index (KDPI) Calculations Results in Improved Transplant Rates and Outcomes in an Elderly Veteran Population

    R. Lopez-Soler1, A. Thorndyke1, C. Trotter1, A. Abadier2, M. Samra1

    1Surgery, Transplantation, Edward Hines Jr. Veterans Administration Hospital, Hines, IL, 2Surgery, Loyola University Medical School, Maywood, IL

    *Purpose: Overall mortality on the kidney transplant waiting list is higher for older patients. The average age of waitlisted veteran patients is 64, with patients…
  • 2022 American Transplant Congress

    Expanded Experience with Ultra-Short Duration Pangenotypic Direct Acting Anti-Viral (DAA) Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic (HCV) Donors to Hepatitis C Negative Kidney Transplant Recipients (KT)

    I. Yakubu, D. Kumar, A. Sharma, M. Levy, L. Kamal, G. Gupta

    Virginia Commonwealth University, Richmond, VA

    *Purpose: Previous studies have shown that HCV D+/R- kidney transplantation is feasible using 8-12 weeks of DAAs. Utilization of abbreviated regimens may obviate the need…
  • 1
  • 2
  • 3
  • …
  • 28
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences